超声引导多点多肋横突阻滞与胸椎旁阻滞用于乳腺癌大手术的非劣效随机试验
主要结局为恢复室内30分钟内最重静息疼痛评分,次级结局为术后24小时恢复质量。结果显示多肋横突阻滞在两项结局上均非劣效于胸椎旁阻滞。
要点
- 多点多肋横突阻滞在恢复室30分钟内最重静息疼痛评分非劣效于多点胸椎旁阻滞。
- 术后24小时恢复质量评分多肋横突阻滞非劣效于胸椎旁阻滞。
- 两组均采用T2-6每点0.5%罗哌卡因5 mL的多点注射方案。
核心结论
- 与多点胸椎旁阻滞相比,多点多肋横突阻滞在乳腺癌大手术女性中恢复室30分钟内镇痛及术后24小时恢复质量均非劣效。
主要发现
- 恢复室30分钟内最重静息疼痛评分:多肋横突阻滞组0(0,1),胸椎旁阻滞组0.5(0,2),中位差0(95%CI 0至0)。
- 术后24小时恢复质量聚合评分:多肋横突阻滞组137.5(126.5,142.8),胸椎旁阻滞组137.5(127.8,145.0),中位差-1(95%CI -6至3)。
关键数值与推荐
- 疼痛非劣效界值为1分,95%CI上限低于1分(非劣效p<0.001)。
- 恢复质量非劣效界值为-8,95%CI下限大于-8(非劣效p=0.006)。
临床怎么用
- 多点多肋横突阻滞可作为多点胸椎旁阻滞的替代方案用于乳腺癌大手术围术期镇痛。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study investigated whether a novel multi-injection intertransverse process block could provide non-inferior analgesia and recovery quality following major breast cancer surgery compared with the multi-injection thoracic paravertebral block. METHODS: Eighty-eight females who underwent mastectomy plus sentinel or axillary lymph node dissection were randomized to receive either intertransverse process block or thoracic paravertebral block, both performed at T2-6 with 5 mL of 0.5% ropivacaine per level. The primary outcome was the worst resting pain score (11-point Numerical Rating Scale) within 30 min in the recovery room. The secondary outcome was recovery quality (15-item quality of recovery scale) 24 hours after surgery, which was tested following a gatekeeping procedure. RESULTS: The worst resting pain scores were 0 (0, 1) in the intertransverse process block group vs 0.5 (0, 2) in the thoracic paravertebral block group, with a median difference of 0 (95% CI 0 to 0); the upper 95% CI limit was lower than the prespecified non-inferiority margin of 1 point (non-inferiority p<0.001). Aggregate scores of recovery quality at 24 hours postoperatively were 137.5 (126.5, 142.8) and 137.5 (127.8, 145.0) for the intertransverse process and thoracic paravertebral block groups, respectively, with a median difference of -1 (95% CI -6 to 3); the lower 95% CI limit was larger than the prespecified non-inferiority margin of -8 (non-inferiority p=0.006). CONCLUSIONS: Compared with a multi-injection thoracic paravertebral block, the multi-injection intertransverse process block provided non-inferior analgesia within 30 min in the recovery room and recovery quality at 24 hours following major breast cancer surgery in females. TRIAL REGISTRATION NUMBER: ChiCTR2000037963.
引用
- Zhang H, Qu Z, Miao Y, et al. Comparison between ultrasound-guided multi-injection intertransverse process and thoracic paravertebral blocks for major breast cancer surgery: a randomized non-inferiority trial. Reg Anesth Pain Med. 2022. PMID: 36522043. doi:10.1136/rapm-2022-104003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。